HIKAL
|
The Current P/B Ratio of HIKAL is 2.91.
Share Price | ₹280.6 | May 13,2024 |
Market Cap | ₹3,459.2 Cr | |
Book Value | ₹1,187.7 Cr | Mar2024 - Consolidated Results |
Price/Book | 2.91x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of HIKAL
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹3,459.2 Cr] as on May 13,2024
(/) Book Value [ ₹1,187.7 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 2.91x ]
Thus, for HIKAL , the investors are currently willing to pay '2.91 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of HIKAL !
The chart below summarizes the trend in P/B Ratio of HIKAL over the last five years.
Historical PB (Price/Book ) ratio chart of HIKAL
PB Ratio Performance Analysis for HIKAL
- HIKAL 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 2.71x.
- HIKAL 's operated at median p/b ratio of 2.85x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HIKAL 's p/b ratio peaked in Mar2022 at 4.65x.
- HIKAL 's p/b ratio hit its five-year low in Mar2020 of 1.06x.
How does HIKAL 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
HIKAL | 1,187.66 | 2.91 | 3,459.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 55,995.40 | 6.54 | 366,103.0 |
CIPLA LTD | 26,706.40 | 4.28 | 114,230.0 |
DR REDDYS LABORATORIES LTD | 28,254.80 | 3.49 | 98,732.2 |
ZYDUS LIFESCIENCES LTD | 17,515.80 | 5.71 | 99,939.2 |
DIVIS LABORATORIES LTD | 12,767.10 | 8.14 | 103,916.0 |
MANKIND PHARMA LTD | 7,435.16 | 11.74 | 87,324.4 |
TORRENT PHARMACEUTICALS LTD | 6,198.07 | 14.22 | 88,139.6 |
LUPIN LTD | 14,290.30 | 5.38 | 76,919.2 |
AUROBINDO PHARMA LTD | 26,839.80 | 2.57 | 69,014.8 |
ABBOTT INDIA LTD | 3,698.89 | 15.54 | 57,465.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs HIKAL 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.57x |
Max industry PB | 15.54x |
Median industry PB | 5.71x |
Average industry PB | 7.32x |
You may also like the below Video Courses